
“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
AB InBev's Mega Bonds Just the Start of a Corporate-Debt Deluge
Clashes erupt as Islamists push back in Egypt
French minister in charge of combating tax avoidance resigns over Swiss bank account
Korea Today - Bitcoin: Currency for the future?
Russia to deploy ‘star wars’ defense system in 2017
China is flooding Silicon Valley with cash
Oklahoma legislator wants to legalize raw milk delivery to homes
Deputies punished for actions during 1:30 am wrong-address arrest
British PM concedes vote on military action should await UN report
Seattle $15/Hour Minimum Wage Being Pushed
Missouri senator's husband reaped $131 million in federal subsidies over 10 years
FBI knew earlier of Boston bombing suspect Tsarnaev
Voluntary government checkpoints spark backlash
Bank of England deputy governor Paul Tucker warned banks they could collapse 'before Christmas'
Meet The 'Assassination Market' Creator Who's Crowdfunding Murder